FDA considers new muscular dystrophy treatment using experim

The FDA is considering greenlighting the experimental treatment under its accelerated approvals program. Some critics point out the therapy isn't yet proven to work and may be costly.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , University Of Florida , Florida , United States , Yale School , Miami , Chris Finazzo , Barry Byrne , Douglas Ingram , Susan Finazzo , Reshma Ramachandran , Chris Finazzowere , Rosa Reyes Susan Finazzo , Debra Miller , Glen Nuckolls , National Institute Of Neurological Disorders , Muscular Dystrophy Association , Drug Administration , Yale School Of Medicine , Natalia De La Rosa , Chase Finazzo , National Institute , Neurological Disorders , Muscular Dystrophy ,